Convergence Investment Partners’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.92M Buy
31,020
+9,818
+46% +$980K 0.48% 63
2025
Q4
$2.09M Buy
21,202
+6,734
+47% +$652K 0.42% 73
2025
Q3
$1.23M Buy
14,468
+10,297
+247% +$814K 0.28% 134
2025
Q2
$284K Buy
+4,171
New +$264K 0.07% 209
2024
Q3
Sell
-3,728
Closed -$226K 265
2024
Q2
$226K Buy
+3,728
New +$211K 0.07% 229
2018
Q2
Sell
-54
Closed -$4K 592
2018
Q1
$4K Buy
+54
New +$4.87K ﹤0.01% 875
2015
Q3
Sell
-15,360
Closed -$1.6M 378
2015
Q2
$1.6M Buy
+15,360
New +$1.59M 0.16% 210
2014
Q1
Sell
-40,554
Closed -$2.05M 400
2013
Q4
$2.05M Buy
+40,554
New +$1.76M 0.33% 111

Other funds holding INCY

Convergence Investment Partners's INCY Position: Q1 2026 in Review

Convergence Investment Partners increased its Incyte (INCY) stake by 46% in Q1 2026, buying an estimated $980K and bringing the position to 31,020 shares worth $2.92M. The position accounts for 0.48% of the portfolio, ranked #63.

Convergence Investment Partners first reported a position in INCY in Q4 2013 and has held it in 8 quarters since. 810 funds tracked by Wall St. Rank hold INCY as of Q1 2026.

  • Convergence Investment Partners held 31,020 shares of Incyte worth $2.92M as of Q1 2026.
  • Convergence Investment Partners bought 9,818 Incyte shares in Q1 2026, an estimated $980K.
  • Incyte made up 0.48% of Convergence Investment Partners's portfolio in Q1 2026, its #63 holding.
  • Convergence Investment Partners first reported a position in Incyte in Q4 2013 and has held it in 8 quarters since.
  • 810 funds tracked by Wall St. Rank held Incyte as of Q1 2026.

Based on Convergence Investment Partners's 13F filing for Q1 2026, filed 7 May 2026.